Sky NewsLecanemab: New Alzheimer's drug slows decline in memory - fuelling hope doctors will one day cure dementiaNov 30, 2022Thomas MooreBy Thomas Mooremore_vert
Alzheimer's Research UKFull lecanemab data presented at CTAD Alzheimer's CongressNov 30, 2022more_vert
ScienceAs some hail new antibody treatment for Alzheimer's, safety and benefit questions persistDec 7, 2022Jennifer Couzin & Charles PillerBy Jennifer Couzin & Charles Pillermore_vert
CBS NewsExperimental drug appears to slow progression of Alzheimer'sNov 30, 2022Stephanie StahlBy Stephanie Stahlmore_vert
STATBrain shrinkage needs closer scrutiny in trials of anti-amyloid drugsNov 28, 2022Madhav Ramakrishna ThambisettyBy Madhav Ramakrishna Thambisettymore_vert
ReutersAlzheimer's drug from Eisai and Biogen slows cognitive decline, side-effects in focusNov 30, 2022Deena BeasleyBy Deena Beasleymore_vert
The GuardianNHS ‘nowhere near ready’ to deliver new Alzheimer’s drug, doctors sayNov 30, 2022Ian SampleBy Ian Samplemore_vert
ABC NewsNew data shows Alzheimer's drug can slow cognitive declineNov 29, 2022Sony Salzman & Mary KekatosBy Sony Salzman & Mary Kekatosmore_vert
The Washington PostAlzheimer's drug shows promise but needs more study for safety, researchers sayNov 29, 2022Daniel GilbertBy Daniel Gilbertmore_vert
CNNExperimental drug appears to slow progression of Alzheimer's disease in clinical trial but raises safety concernsNov 30, 2022Jacqueline HowardBy Jacqueline Howardmore_vert
NPRAlzheimer's drug lecanemab may slow losses in memory and thinking, study says : Shots - Health NewsNov 30, 2022Jon HamiltonBy Jon Hamiltonmore_vert
BBC.comAlzheimer's drug lecanemab hailed as momentous breakthroughNov 30, 2022James GallagherBy James Gallaghermore_vert
ReutersFocus: Rare success for Alzheimer's research unlocks hope for future therapiesNov 29, 2022Julie SteenhuysenBy Julie Steenhuysenmore_vert
ScienceSecond death linked to potential antibody treatment for Alzheimer's diseaseNov 27, 2022Charles PillerBy Charles Pillermore_vert
The New York TimesAlzheimer's Drug May Benefit Some Patients, New Data Shows (Published 2022)Nov 29, 2022Pam BelluckBy Pam Belluckmore_vert
The GuardianDrug slows cognitive decline in Alzheimer’s patients, study revealsNov 30, 2022Ian SampleBy Ian Samplemore_vert
The GuardianIt’s just a first step, but this new Alzheimer’s drug could be a huge breakthroughNov 30, 2022Jonathan SchottBy Jonathan Schottmore_vert